Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
454 Cards in this Set
- Front
- Back
Preload
|
passive load that establishes the initial muscle length of the cardiac fibers prior to contraction
(left ventricular end-diastolic volume) |
|
after load
|
sum of all loads against which the myocardial fibers must shorten during systole.
aortic impedance arterial resistance intraventricular pressure mass and viscosity of blood in the great vessels |
|
contractility
|
speed and shortening capacity at a given instantaneous load (ionotropy)
|
|
diastolic compliance
|
the ability to fill at a given diastolic pressure
|
|
heart rate
|
frequency of contraction
|
|
ejection fraction
|
end diastolic minus end systolic/end diastolic volume
most wildly used clinical indicator of LV function |
|
P wave
|
atrial contraction (depolarization)
|
|
QRS wave
|
ventricular contraction (depolarization)
hides atrial repolarization |
|
T wave
|
ventricular relaxation
|
|
systemic vascular resistance =
|
blood pressure/ cardiac output
|
|
Blood pressure =
|
= systemic vascular resistance (SVR) x cardiac output
|
|
cardiac output =
|
HR x stroke volume
|
|
Thin filaments components
|
G-actin (globular) polymerizes to form F actin (filamentous)
Tropomyosyin helps hold F-actin together |
|
Troponin complex
|
Troponin T - binds tropomyosin, anchoring the troponin complex
Troponin C - binds Calcium Troponin I - binds to actin, inhibiting actin-myosin interaction |
|
Thick filaments of muscle
|
4 lights chains - structural role
2 heavy chains - each has biding site for ATP and a binding site for actin also has ATPase activity/motor activity |
|
Sarcomere Organization
Z band |
Thin filaments bind to z line
|
|
sarcomere organization
H zone |
middle of the sarcomere (z to z is one sarcomere)
|
|
Sarcomere organization
M line |
thick bind to M line
|
|
Muscle contraction
stages: |
Attachment
release bend force generation Attachment repeat |
|
muscle contraction
attachment |
ATP not present
get myosin head binding to actin |
|
Muscle contraction
Release |
ATP causes detachment of myosin head from actin
ATP causes a conformational change, myosin head loses affinity for actin |
|
muscle contraction
bends |
myosin head bends to original state
movement initiated by breakdown of ATP to ADP bends towards Z line |
|
muscle contraction
force generation |
myosin head binds weakly to a new actin molecule (closer to Z line) only when calcium is present (calcium dependent)
phosphate is released, increasing the binding affinity, head returns to original position. As it returns, it pulls the thin filament along thick filaments (power stroke) |
|
Regulators of contraction:
|
ATP
calcium magnesium - requires ATPase activity Na and channels beta adrenergic receptors |
|
Cardiac muscle contraction
|
action potential moves down T tubule
AP detected by DHP receptors that contain Ca channel DHP opens to allow a small amount of extracellular Ca into the fiber Ca binds to ryanodine receptors in the SR, opening SR to release large amount of calcium Calcium release allows contraction of cardiac muscle |
|
Cardiac AP and calcium influx
|
sodium initially flows in for AP
calcium then flows in, depolarization occurs repolarization occurs with the outflow of potassium ions |
|
Function of intercalated disks
|
attachments of cells to other cells
allows conduction of AP linearly only found in cardiac muscle |
|
structure of intercalated disks
|
(1) transverse component
major component is Fascia adherens - holds cells together to form fibers (2) later component each component has cell to cell junctions fascia adherens maculae adherens - help prevent cells from pulling apart under tension, in both components gap junctions - major element of lateral component provide ionic continuity among adjacent cardiac muscle cells, permit cardiac muscle cells to behave as syncytium |
|
SA node cells
|
small
disorganized no intercalated disks slow depolarization in the late stage of each action potential |
|
AV node cells
|
located in right atrium, near lower part of interatrial septum
small, few myofilaments, less organized, no intercalated disks depolarize slowly (delay signal from SA node) - allows for delay in contraction of atria relative to ventricles....atria squeeze all the blood into the ventricles before ventricles contract |
|
Purkinje and bundle fibers
|
from the AV node, transmit signal
transitional cells that end on myocardium Purkinje cells - larger than cardiac muscle cells large amounts of glycogen, few organized myofilaments infrequent intercalated disks, frequent gap junctions |
|
Neural regulation of heart
|
ANS -
parasympathetics - from vagus synapse on post synamptic in heart, terminate in SA/AV node Para - use ACh to decrease HR sympathetics from T1-T6 use NE to increase HR |
|
Sequence of heart contraction
|
(1) SA node generates impulse
(2) AV node delays impulse (3) impulse passes from atria to ventricles via the atrioventricular bundle of his (bundle to apex, and purkinje fibers to apex) |
|
Systole
|
contraction
|
|
diastole
|
relaxation
|
|
ventricular filling
|
mid to late diastole
blood pressure low Av valves open then atrial systole |
|
ventricular systole
|
atria relax
rising ventricular pressure results in closing of AV valves isovolumetric contraction phase ventricular ejection phase opens semilunar valves isovolumetric relaxation occurrs |
|
Factors affecting stroke volume
Frank Starling Law |
(1)preload - amount ventricles are stretched by blood before contraction
increase SV with low heartbeat or exercise decrease SV with extremely rapid HR or blood loss (2) contractility - increase with some drugs/hormones...NE decreased with acidosis, increased extracellular K, calcium channel blockers... |
|
depolarization of SA node process
|
slow leak of calcium in, calcium released within the cell, potassium repolarizes cells
phase 0,3,4 only |
|
Sodium propagation of signal
|
hits an L type calcium channel at teh bottom of the T tubule
allows calcium influx calcium binds to ryanodine receptor on SR calcium released within the cell calcium binds to tropomyosin complex and shifts tropomyosin I (inhibitor) away from the myosin/actin binding site myosin head interacts with actin phosphate from hydrolyzed ATP is released, myosin head bends (get contraction) calcium regulated, ATP dependent shortening of filaments |
|
cardiac cycle
|
ventricle contracts - isovolumetric increase in pressure
when pressure equals aorta, aortic valve opens...ejection of blood end of systole - myosin/actin dissociate isovolumetric decrease in pressure when pressure equal to atria, mitral valve opens atria contract, ventricle full...repeat isovolumetric contraction |
|
Regulation of cardiac cycle by brainstem
|
sympathetics - NE binds to beta 1 receptor...sends signals to increase sodium and calcium influx...causes an increase in depolarization (increased HR)
parasympathetics - ACh binds to muscaranic receptors and causes a decrease in Na/Ca...causes hyperpolarization |
|
Frank Starling Mechanism and preload
|
if you stretch a muscle, you increase its performance
increase preload by aortic regurgitation exercise - rapid relaxation and lower pressure increases stroke volume valsalva - decreases atrial fibrillation - decreases preload |
|
Frank Starling Mechanism and afterload
|
afterload is the force that the ventricle must overcome to eject blood (mean arterial pressure) or aortic valve/outflow tract resistance
higher afterload results in longer isovolumetric contraction and slower rate of muscle fiber shortening |
|
Frank Starling Mechanism and contractility
|
change in end systolic pressure volume relationship
increased contractility results in a greater stroke volume at any given preload or afterload |
|
CHF physiology
|
rest: ventricle can still get low enough pressure to fill
exercise: can't relax as well...ventricle can't get low enough pressure, atrial pressure must increase to improve stroke volume, must have higher end diastolic pressure results in higher Left Atrial pressure, which results in pulmonary congestion, pulmonary congestion causes shortness of breath, shortness of breath increases disability |
|
CHF pathology
|
usually starts with myocardial insult
myocardial dysfunction - reduced system perfusion hemodynamic defense systems activated (normally suppose to be transient)...get altered gene expression, apoptosis, remodeling |
|
Hemodynamic defense systems
|
(1) Sympathetic - NE
(2) rennin angiotensin (3) aldosterone |
|
Sympathetic as hemodynamic defense
|
NE
binds beta/alpha receptors organs - cardiovascular, adrenal gland cardiac - increase in automaticity, contractility, afterload, myocyte death |
|
Renin angiotensin as hemodynamic defense
|
Angiotensin II
organs - kidney, lungs, cardiovascular increases afterload and preload, myocyte hypertrophy |
|
Aldosterone as hemodynamic defense
|
aldosterone
organs - kidney, heart causes cardiac fibrosis |
|
Staging of CHF
|
(a) high risk but no structural changes in heart
(b) structural changes without syndrome (c) syndrome controlled by therapy (d) syndrome uncontrolled despite therapy |
|
CHF symptom staging
|
1 no limitation of activity
2 mild limitation improves with slowing down 3 marked limitation improves only with rest 4 severe limitation or symptoms at rest |
|
CHF types
|
(1) diastole - thick non functioning heart, unable to fill
(2) systolic CHF - thin, large dysfunctional heart, unable to pump and unable to fill |
|
Diastolic CHF
|
no change in heart volume
unable to fill concentric hypertrophy of myocytes near normal stroke volume normal end diastolic volume steep diastolic pressure preload volume |
|
Systolic CHF
|
unable to fill and unable to pump
increase in heart volume eccentric hypertrophy of myocytes steep diastolic pressure preload volume low stroke volume high end diastolic volume |
|
Organization of the heart wall
|
(1) endocardium - endothelial cells over connective tissue
collagenous connective tiisue simple squamous epithelial cells on surface (2) myocardium - cardiac muscle (3) epicardium - connective tissue with blood vessels and nerve fibers, covered by layer of mesothelial cells |
|
endocardium
|
endothelial cells over connective tissue
collagenous connective tissue simple squamous epithelial cells on surface |
|
myocardium
|
cardiac muscle with small amounts of connective tissue
richly vascularized |
|
epicardium
|
connective tissue with blood vessels and nerve fibers
covered by layer of mesothelial cells contains nerve bundles, larger blood vessels, and large fat deposits |
|
fibrous skeleton of the heart location and function
|
(1) where ventricles/atria met
(2) where great vessels arise function (a) extends partially into interventricular septum to anchor valves (b) eletrically isolates right atrium from ventricles |
|
gross structure of valves
|
form as extension of the endocardium
leaflets of collagenous tissue covered by endothelium that is continious with tha tof the chambers and the great vessels central fibrous sheet (lamina fibrosa) is formed by margining of fibroelastic supporting layers beneath the endothelium cardiac muscle of the myocardium does not extend into the valve, the valves are passive structures |
|
histological structure of the valves
|
spongiosa - atrial side, underneath the endothelium
fibrosa - forms the bulk of the dense connective tissue in the valve ventricularis - the dense connective tissue with layers of collagen and elastic fibers |
|
Atrial cardiac cells
|
contain endocrine granules filled with atrial natriuretic hormone
secrete hormone when overly stretched increases excretion of water, sodium, and potassium by kidneys decreases BP by inhibitin rennin secretion and aldosterone secretion |
|
vascularization of cardiac muscle
|
enter through epicardium
form many anastomoses |
|
Structure of blood vessels
|
(1) tunica intima - closest to lumen.
(2) tunica media - middle layer with elements oriented circumferentially (3) tunica adventitia - outermost layer with elemeents ordered longitudinally |
|
Tunica intima
|
closest to lumen
endothelial cells oriented along direction of blood flow endothelium with basal lamina internal elastic membrane variable subendothelial connective tissue substanital in elastic arteries smooth muscle cells produce the collagen and elastic fibers |
|
tunica media
|
middle layer with elements oriented circumferentially
smooth muscle variable amount of elastin and collagen dominant layer in arteries |
|
tunica adventitia
|
outermost layer with elements ordered longitudinally
collagenous fibers and a few elastic fibers major component in veins with significant smooth muscle contains vaso casorum and nervi vascularis in large vessels |
|
endothelium
|
provides smooth, low resistance surface for flow
cell bound by junctional complexes and may have pinocytotic vesicles secrete factors that maintain smooth muscle can be activated by cytokines to express cell adhesion molecules that allow WBC to stick |
|
atherosclerotic plaque
|
occupies tunica intima and expands it
contains connective tissue fibers, smooth muscle cells, lipid containing macrophages, necrotic material, cholesterl clefts |
|
tunica media
|
shows greatest variation and structural specialization
large elastic arteries - media in concentric layers of elastic and smooth muscle muscular arteries - have prominent media of smooth muscle (circumferential) bounded by internal and external elastic laminae arterioles - few layers of smooth muscle, very responsive to vasoactive stimuli elastic arteries - intima is longitudinally oriented with subendothelial connective tissue |
|
general structure of muscular arteries
|
sparse endothelial connective tissue
prominent internal elastic membrane prominent smooth muscle in t. media longitudinally oriented, incomplete lamellae connective tissue in t. adventitia |
|
arteriole structure
|
smallest branches of arteries
start of microvascular system intimate endothelial cells with basement membrane t. media has 1-2 layers of smooth muscle, smooth muscle becomes discontinous t. adventitia is insignificant small lumen relative to thickness of vessel wall prominent endothelial nuclei |
|
venules
|
postcap -> collecting -> muscular venules
large lumen compared to vessel thickness post cap - site of migration of leukocytes out of blood stream and into peripheral tissue regulated by factors produced by endothelial cells and cells outside of circulation |
|
medium veins
|
irregular profile, larger lumen, thinner walls
more distinct t. intima, media and adventitia sparse subendothelial connective tissue beneath endothelial cells adventitia thicker than media smooth muscle cells in media and adventitia |
|
vein valves
|
in small/medium
develop as inelastic extensions of the t. intima but covered by endothelial cells |
|
structure of large veins
|
t intima thin
t media circumferentially oriented smooth muscle cells, fibroblasts, and collagenous fibers t adventitia thickest layer, prominent bundles of smooth muscle separated by connective tissue |
|
microvasculature structure
|
capillaries arise from metarterioles
smooth muscle in t. media is discontinous form precapillary sphincters contraction and relaxation of these sphincters regulates blood flow pericytes help regulate capillary diameter |
|
microstructure of capillaries
|
thin walls to permit exchange
capillary wall - endothelial cells, basal lamina covers pericytes, scattered contractile cells (pericytes) endothelial cells make contact without gap junctions (selective permeability barrier) |
|
capillary types
|
(1) continuous - form tight junctions
movement of material requires carried mediated transport in pinocytotic vesicles... muscle, never, connective tissue (2) fenestrated capillaries - contain fenestrae bridged by diaphagms of extracellular material basal lamina is continuous pancreas, intestines, endocrine glands, renal glomeruli |
|
sinusoids
|
discontinuous capillaries
large diameter, thin walled large fenestrae without diaphragms, gaps between endothelial cells, little basal lamina greater amount of transport found in bone marrow, liver, spleen, lymphoid organs |
|
blood flow and capillaries
|
thorough fare channels bypass capillary beds - no sphincters
contraction of precap sphincters directs flow from bed to AV shunts or other way around blood flow - greatest total cross sectional area, lowest velocity velocity of flow depends on total cross sectional area, not individual diameters |
|
Portal systems
|
vein or artery between to beds
hepatic portal system, hypothalamic-hyphophyseal portal system, kidney efferent arterioles carry blood from glomerulus to peritubular capillaries |
|
capillary exchange
|
hydrostatic pressure drives fluid out of caps
highest on arterial side bulk flow in on venule side protein stays in, water/oxygen/glucose out Co2, N wastes, water move in |
|
lymphatic capillaries
|
single layer of endothelial cells with an incomplete basal lamina
endothelial cells overlap partially but have intercellular spaces for access to lumen no fenestrae or tight junctions anchoring elements terminate on abluminal plasma membrane more fluid in tissues means higher extracellular hydrostatic pressure, forcing fluid into lymph small/medium have closely spaced valves to ensure one way flow flow maintained by muscle contractions |
|
lymph drainage areas
|
(1)Rt side - above diaphragm, rt side head/neck..rt upper arm
drains into rt subclavian (2) left - left head/neck arm. lower body temporarily stored in cistern chyli thoracic duct carries lymph to left lymphatic duct drains into left subclavian |
|
Transcytosis
|
process by which molecules are transported from blood plasma across endothelial wall
|
|
Pathogenesis of Artherosclerosis
|
(1)LDL/VLDL binds to charged proteoglycans instead of normally leaking back out to blood
(2)oxidized lipidsinduce the endothelial cells to begin producing adhesion molecules (selectins, VCAM1 and MCP1) (3)selectins allow monocytes and T cells to roll along surface and invade arterial wall (4)monocytes become macrophages and begin producing pro-inflammatory cytokines that attrct more cells to invade wall to consume lipids (5) macrophages also produce oxidizing agents that modify LDL/VLDL (6)SR-A receptor binds to modified lipids |
|
macrophage to foam cell
|
LDL endocytosed
goes to lysosome chopped into fragments fragments are effluxed to HDL or make into cholesterol esters Esters build up in cell = foam cell |
|
role of PDGF in artherosclerosis
|
produced by macrophages
tells smooth muscle cells to migrate from t. media to intima begin producing fibromuscular cap |
|
T cell cytokines and smooth muscle cells
|
cytokines inhibit smooth muscle cell proliferation and collagen production
destabilize plaque |
|
fate of macrophage foam cells
|
some die and relase contents within the intima
activates neighboring macrophages to produce more pro-inflammatory cytokines |
|
plaque rupturing
|
macrophage foam cells secrete MMP that breaks down collagen
foam cells tend to concentrate at edges of plaque...destabilizing edges rupture interrupts the anti-thrombogenic endothelial cell surface and causes platelet aggregation |
|
major risk factors for atherosclerosis
|
age
male gender |
|
primary risk factors for atherosclerosis
|
high LDL
low HDL hypertension cigarette smoking diabetes |
|
secondary risk factors for atherosclerosis
|
obesity
sedentary life style |
|
Role of female sex hormones in atherosclerosis
|
progesterone and estrogen given after menopause increase risk of stroke, breast cancer with no affect on CHD
estrogen given close to menopause reduces risk atherosclerosis unknown: protective if given at time of menopause if estrogen is only reason for less atherosclerosis in women |
|
Primary prevention for atherosclerosis
|
reduction of LDL and plaque = primary prevention
most cholesterol comes from synthesis (not diet) statin drugs reduce LDL and reduce initial event for CHD |
|
secondary prevention for atherosclerosis
|
stabilize plaque
aggressive lowering of plasma cholesterol concentrations stabilizes plaque and reduces risk of rupture |
|
HDL and atherosclerosis
|
HDL mediates cholesterol efflux
binds to macrophage ABCA1 and ABCG1 transporters reverses cholesterol transport Anti-inflammatory by reducing expression of adhesion molecules (p-selectin, VCAM1) on endothelial cells stimulates nitric oxide production which stimulates vasodilation |
|
Resistance to blood flow
|
vessel length
blood viscosity and RADIUS |
|
resistance in vessels in series vs parallel
|
series - changing resistance of one vessel, dramatically changes over all resistance
parallel - changing one vessel has little effect on total resistance |
|
parasympathetic
|
preganglionic long, synapse near organ
Neurotrans = ACh Receptor = nicotinic postganglionic are short NT = ACh receptor = muscarinic |
|
Parasympathetic nervous in cardiovascular
|
vagal fibers innervate the heart...originate in the dorsal vagal nucleus/nucleus ambiguous
have tonic tone - always on vagal efferents from medulla travel to SA (rt vagal) and AV (left vagal) |
|
sympathetic nervous system
|
preganglionic fibers are short
NT = ACh receptor = nicotinic postganglionics are long NT= NE receptor = Alpha/beta adrenergics |
|
Sympathetics in cardiovascular system
|
adrenergic control of heart and blood vessels originates in medulla
spontaneous activity - always on increases HR and contractility |
|
Neural control of circulation
Arterial baroreflex - sympathetics |
carotid sinus and aortic arch
stretch receptors fire rate increases with increased pressure (stretch) respond to mean pressure, changes in pulse pressure, and pressure over time very sensitive to small changes |
|
BP neural projections in the medulla
|
initially project to nucleus solitarius
then go to either (1)depressor center - caudal ventrolateral medulla (CVLM) and decreases BP or go to (2)pressor center - rostral ventrolateral medulla (RVLM) and increase BP CVLM inhibits RVLM |
|
parasympathetic baroreflex
|
tonically active...arise in dorsal vagal/ambiguous
(1)excitatory connection to dorsl motor nucleus of vagas (DMN X) and the nucleus ambiguous (NA) (2)inhibitory projections directly on end organs |
|
Cardiopulmonary reflexes
|
stretch receptors in the heart - particularly atrium
relate blood volume increase in blood volume leads to increased sympathetic activation and diuresis |
|
Chemoreceptor reflexes
|
monitor oxygen, CO2 and H+
peripherally located in carotid and aortic body also centrally in medulla Regulate: respiratory activity to maintain normal pH, pO2 and pCO2 send to nucleus solitarius |
|
Humoral control
|
(1) catecholamines
(2)Renin-Angiotensin-Aldosterone System (3)Vasopressin (4)Atrial natriuretic peptide |
|
Humoral control
catecholamines |
released by adrenal medulla (epinerpherine and NE)
stimulates renin release and subsequently AngII and aldosterone |
|
humoral control
renin angiotensin aldosterone system |
regulates blood volume and pressure (long term)
kidney main organ regulated by: sympathetics, renal artery hypotension, decreased sodium mechanism: renin converts angiotensinogen to A1, A1 becomes A2. A2 modulates many cardiovascular events stimulates muscle mass in ventricles stimulates vasoconstriction stimulates thirst stimulates aldosterone - kidney retains fluid |
|
humoral control
vasopressin |
released by posterior pituitary
acts at kidney (1) increases fluid reabsorption (2)vasoconstriction |
|
humoral control
atrial natriuretic peptide |
stored atrial myocytes
released by stretch and Ang2 counter balances RAAS by vasodilation and fluid release |
|
vasodilator reserve
|
difference between basal and maximal flow
|
|
AV O2 difference
|
measure of oxygen extraction between arterial and venous sides
small differences suggest that additional oxygen can be extracted without greatly increasing flow |
|
active hyperemia
|
increase in blood flow in response to metabolic demand
|
|
reactive hyperemia
|
blood flow increase in response to brief periods of ischemia
|
|
Tissue Factor control of vasculature
|
originate in surrounding tissue or paracrine cells
vasodilator or constrictor interact with endothelium or smooth muscle |
|
endothelial factors and circulatory control
|
endocrine, paracrine, or autocrine
physical factors - shear stress may act on endothelial or on smooth muscle vasodilator/constrictor |
|
myogenic response
|
originates within the smooth muscle of arteries/arterioles
occur in response to sudden change in pressure increased pressure, smooth muscle constricts to preserve vascular resistance and diameter |
|
vasodilators
|
NE, PE, O2
|
|
special circulations
|
(1) coronary
(2)cerebral circulation (3)skeletal muscle (4)cutaneous blood flow (5)splanchnic circulation (6) renal circulation (7) pulmonary circulation |
|
special circulation
coronary |
major vessels lie on epicardial surface = low resistance
branches dive into myocardim - act as regulators Pulsatile perfusion - diastolic flow...compressive forces high during systole so not a lot of flow during systole large vasodilator reserve highly regulated by tissue metabolism (adenosine) little oxygen extraction reserve |
|
special circulation
cerebral circulatoin |
circle of willis
rigid structure so in flow must equal out flow endothelium has tight junctions and a basement membrane = BBB blood flow tightly coupled to oxygen demand predominant control of cerebral circulation is determined by local factors (CO2) |
|
special circulation
skeletal muscle |
blood flow to satisfy metabolic demand
vascular anatomy is highly organized - capillaries can be recruited if high demand type of exercise changes blood flow - sustained contraction (reactive hyperemia) vs phasic (active hyperemia) control: myogenic tone muscle contraction can occlude vessels metabolites - can override sympathetic control of vascular tone |
|
special circulation
cutatenous blood floow |
primary function = maintain body temp
regulation is neural regulation at deeper AV anastomoses Neural control: tonic sympathetic vasoconstriction Raynaurds syndrome - too much constriction (ischemia, cold hands) |
|
special circulation
splanchnic circulation |
receives large portion of blood volume
can redistribute blood elsewhere (compensatory adjustments) if blood loss neural control: sympathetic innervations of arterioles and veins high resting sympathetic vasoconstriction tone |
|
special circulation
renal circulation |
receives relatively high blood flow but is constant
primary function - salt and water balance...long term BP control through blood volume anatomy: two capillary segments in series...glomerular and peritubular important for filtration and reabsorption strong auto-regulation doesnt respond to sympathetic stimulation |
|
special circulation
pulmonary circulation |
(a) pulmonary - supplies blood to alveoli for gas exchange
dervived from RT ventricle low resistance, low pressure hypoxia causes vasoconstriction to preserve blood flow to functional alveoli (b) bronchial derived from aorta nutritive flow to trachea and bronchial structures |
|
Epidemiology of PAD
|
8-12 million Americans
chronic process evolving over several decades M=F |
|
Area most commonly affected in PAD
|
abdominal aorta
lesion area greater in women greater in smokers pain when stenosis >75% |
|
PAD presentation
|
gradual onset
exertional aching pain, cramping, tightness, fatigue occurs in MUSCLE GROUPS not joint reproducible pain (exact same amount of exercise every time) resolves with rest |
|
Types of claudication
|
(1) intermittent arterial claudication
(2) spinal neurological or pseudo claudication (3) venous claudication (4) arthritic claudication....good days/bad days |
|
pseudoclaudication
|
musculosketal disease
location in the same place pain similar but problems still occur at rest good days bad days pain doesnt go away with standing |
|
lifestyle consequences of claudication
|
functional ability similar to NYHA class III CHF
|
|
Buerger's Disease vs atherosclerotic disease
|
athero - have cardiovascular risks
smoking common in both men = women location - aorto iliac, coronaries, carotids phlebitis - very rare |
|
thrombosis vs embolism in claudication
|
embolism - 70%
sudden, no distal pulses, no collaterals, frequently bilateral source: cardiac atheroemboli paradoxical - DVT thrombosis - 30% distal pulses, collaterals, origin - aneurysm arterial occlusive disease - hyper coag state or atherothrombosis/buerger's disease |
|
Atheromatous embolization
|
causes of thrombembolus
trauma, invasive procedures legs most common site (then kidneys) blue toe sign livedo reticularis |
|
risk factors for PAD
|
Age
diabetes smoking lipids: high triglycerides low HDL family hx in young |
|
Ankle Brachial Index (ABI)
|
= lower extremeity systolic/brachial systolic
use highest brachial lowest calculated ABI for diagnosis of PAD |
|
Non-invasive evaluation of lower extremity circulation
|
(1) ABI
(2) Resting segmental pressures (3) resting pulse volume recordings (4) Exercise testing (5) Duplex utrasound (6) Transcutaneous oximetry |
|
Sites of extremity atherosclerosis
|
any bifurcation in arteries
CFA, SFA, profunda femoris tibial, peroneal aorto-iliac |
|
Major collateral pathways in legs
|
(1) lumbar aortic branches (aortic disease)
(2) internal iliac system and pelvic circulation (CIA disease) (3) circumflex femoral arteries (CFA disease) (4) profunda femoris (SFA disease) (5) geniculate arteries (PA disease) |
|
Leriche's Syndrome
|
focal occlusive disease of distal aorta and proximal iliac
findings - small caliber abdominal aorta multiple periaortic adhesions calcified atherosclerotic plaque and thrombosis operation - aorto iliac endarderectomy; aorto bi iliac bypass |
|
Post op for all PAD patients
|
BP control
130/80 for renal and diabetics 140/90 for others lipid control diabetes control smoking cessation platelet control |
|
Plavix vs aspirin platelet control in PAD
|
plavix
|
|
Medical intervention for PAD
|
exercise
smoking cessation cilostazol - improves claudication, but dont use with heart failure MAO: inhibits PDE III blocks platelet aggregation, blocks thrombosis, vasodilation of collaterals |
|
Cilostazol
|
improves caludication
dont use with CHF patients MAO: inhibits phosphodiesterase III blocks platelet aggregation, blocks thrombosis, vasodilation of collaterals |
|
Surgical intervention for PAD
|
better improvement of clinical symptoms
|
|
screening for PAD
|
any patient with exertional leg pain
>50 with risk factors >40 with strong risk factors all patients over 70 |
|
Renin in renal stenosis
|
less blood flow, release Renin
Renin converts angiotensinogen to A1 ACE converts A1 to A2 A2 causes: vasoconstriction renal sodium retention aldosterone secretion LV Hypertrophy, remodeling, endothelin release sympathetic nervous activation |
|
Unilateral renal stenosis and renin
|
abnormal kidney activates RAAS
contralateral has increased perfusion, increases sodium excretion net effect: plasma renin elevated |
|
bilateral renal stenosis and renin
|
both activate renin
impaired sodium, water retention once volume adequate get steady state: plasma renin is normal patient is hypertensive |
|
clinical implications of renal stenosis
|
paroxysmal hypertension - marked spikes in BP
treatment resistant hypertension hypertensive nephropathy renal failure flash pulmonary edema accelerated cardiovascular disease |
|
children with renal lesions
|
correctable before 10 yo
|
|
prevalence of adults with hypertension
|
24% have renal vascular disease
older and BP>110 and renal insufficiency = more likely to have stenosis |
|
causes of renal stenosis lesions
|
(1)atherosclerosis - 75%
(2) fibromuscular dysplasia - 20% and in younger people (3) miscellaneous |
|
fibromuscular dysplasia
|
(1) medial fibroplasias - 85%
more common in women (2) intimal fibroplasias - 5% focal and in children arteries affected: renal carotid iliac can have aneurysms |
|
tests for reno-vascular disease
|
(1) functional -
rapid sequence excretory urography peripheral plasma renin isotopic renography (2) anatomic angiography MRI/MRA/CTA |
|
isotopic renography
|
measures filtered radioactive tracer before and after ACE inhibitor
angiotensin II maintains GFR in kidney with renal stenosis via increased vasoconstriction in efferent arteriole ACE inhibitor reduces synthesis of A2, diminishes efferent arteriole vasoconstriction and thus a decreased GFR therefore less uptake of filtered radioactive tracer after ACE inhibitor |
|
when to intervene in renal stenosis
|
severe
bilateral rapidly deteriorating renal function normal distal renal artery |
|
visceral ischemic syndromes: mesenterics
acute vs chronic |
acute - sudden onset
usually artery occlusion mesenteric vein occlusion - more likely to cause gangrene of bowel non-obstructive mesenteric ischemia - no lesion, large portion threatening to die off...just enough ishcemia to cause potential death chronic - due to atherosclerosis |
|
incidence of mesenteric ischemia
|
mesenteric artery occlusion - 75%
thrombus - 65% embolus - 35% mesenteric vein occlusion - 15% non-obstructive mesenteric ischemia - 10% |
|
risk factors for mesenteric ischemia
|
age >60
atrial fibrillation CHF recent MI clotting disorder hypercoaguable hypOvolemia |
|
embolus vs thrombosis in visceral ischemia
|
embolus - sudden onset
paucity of physical findings - extreme pain out of proportion bowel evacuation cardiac embolic risk thrombosis - insidious abdominal pain systemic toxicity |
|
mesenteric vein occlusion
|
insidious, diffuse abdominal pain
vague prodromal period nausea, vomiting, distention hypovolemic cardiovascular collapse causes: secondary infection clotting disorder inflammatory bowel disease |
|
NOMI
|
spasm of blood vessel in bowel
|
|
chronic mesenteric ischemia
|
fear of food
weight loss post-prandial (after eating) abdominal pain |
|
dx of ischemic visceral syndromes
|
CT
angiography duplex |
|
tx of ischemic visceral
|
can use local medical
embolus - surgery to remove |
|
survival of visceral ischemia
|
remote organ dysfunction - systemic inflammatory response
main reason for death renal insufficiency hepatocellular dysfunction survival - 20% in five years |
|
venous anatomy of legs
|
deep system - within muscle and fascia
superficial system - drains into the deep perforators connect the two |
|
vein wall
|
has some components as an arterial wall (intima, media, adventitia)
muscular layer (media) not prominent in veins |
|
venous physiology
|
post capillary blood collects in venules, drains into larger veins
superficial drains to deep |
|
vein valves
|
allows flow towards larger tracts
prevent back flow often found at junction and perforators reduce column heihgt of blood to reduce STATIC PRESSURE |
|
hydrostatic pressure in veins
|
static pressure of fluid column
transmitted right atrial pressure overall volume status thoracoabdominal pressure |
|
muscle pump in veins
|
hydrodynamic pressure
calf muscles surround deep veins and the muscles are covered in fascial linings muscle contraction increases the compartment pressure and forces blood out of the deep veins valves prevent back flow to superficial system...propel blood to deep veins |
|
pathophysiology of venous disorders
|
(1) valve failure - increased column height increases static pressure
(2) obstruction (3) thromboembolus effects: additional valve failure capillary bed - edema inflammation chronically - get structural changes and inflammation of surrounding tissue |
|
varicose veins
|
genetic component
valve incompetence - saphenofemoral, saphenopopliteal, perforators pain, aching sensation Tx. compression stocking, elevation, removal of varicosities and any reflux |
|
Telangiectasias - spider veins
|
same proces as varicose veins but on small scale
symptoms - cosmetic, occasional pain tx - exclude larger vein reflux injection sclerotherapy, laser |
|
skin changes with venous stasis
|
lipodermatosclerosis
pgimentation - hemosiderin deposition eczema ulceration - often perforating vein gaiter area - common site |
|
management of varicose veins
|
aggressive compression
elevation antibiotics and debridement when infected skin grafts |
|
DVT
risk factors |
local effects and embolization
age prior hx trauma malignancy exogenous estrogens obesity surgery - hip, knee, pelvic malignancy - sometimes get DVT many years later get a malignancy |
|
DVT dx, hx, pe
|
warmth, redness
homan's sign d-dimer labs imaging is the best...venous duplex |
|
DVT sequlae
|
local - swelling distal
long term potential for dysfunction (morbidity) systemic - postphlebitic syndrome or thrombo-emboli (mortality) |
|
DVT prevention/tx
|
mechanical compressors
pham - anticoags tx. anti coags and compression socks |
|
Phlegmasia Cerulea Dolens
|
limb threatening extensive venous trhombosis
often associated with cancer limb threatening, need emergency surgery |
|
lymphatic disorders
|
extensive interstial fluid enters lymphatic capillaries
have valves too, usually fail drainage dependent on compression forces 80% drain into left chest |
|
lymphedema
|
protein rich
interstial volume overload failed lymph drainage |
|
edema
|
increased interstial fluid volume
|
|
primary lymphedema
|
inherent defect within lymph conduits
|
|
secondary lymphedema
|
acquired damage to lymph conduits
|
|
types of primary lymphedema
|
(1) congenital - milroy's disease
(2) lymphedema praecox - most common <35 yo usually unilateral, adolescent women hypoplastic lymphatics (3) lymphedema tarda - congenitally weakened lymphatics event triggers onset >35 yo |
|
secondary lymphedema
|
obstruction
most common in the world = filariasis most common in US = treatments from other malignancy |
|
skin changes with lymphedema
|
fibrosis
hyperkaratotic |
|
tx for lymphedema
|
no cure
elevation minimal effect exercise helpful compression with massage manual lymph drainage |
|
Stroke -
|
focal neurlogical deficit related to neuronal cell death with signs and symptoms lasting greater than 24 hrs
|
|
TIA
|
a focal neurological deficit with signs and symptoms lasting less than 24 hrs
|
|
risk factors for stroke
|
Hypertension - most major modifiable risk factor
increasing age cardiovascular disease: atrial fibrillation smoking carotid stenosis |
|
stroke etiology
|
ischemia - 80%
embolism - major cause hemorrhage - 20% |
|
stroke pathophysiology
|
cardiac most common source - atrial fibrillation
atherothrombotic carotid stenosis lacunar infarcts - diabetes and hypertension |
|
atherothrombotic stroke
|
major cause of preventable stroke
carotid disease vertebrobasillar disease hypotension - watershed strokes |
|
carotid disease and stroke
|
anatomy - disease of the carotid bulb
rich source of emboli embolic risk related to plaque burden predominantly atherosclerotic other causes - fibromuscular dysplasia arthritis - takayasu's giant cell arthritis dissections radiation |
|
risk factors of carotid disease and stroke
|
advanced age
cigarette smoking HYPERTENSION cardiovascular disease hyperlipidemia |
|
carotid disease stroke presentation
|
TIA
amaurosis fugax completed stroke vertebrobasillar symptoms |
|
TIA presentation
|
contralateral paresis
contralateral numbness aphasia |
|
Amaurosis fugax
|
temproary ipsilateral monocular visual loss due to embolization of retinal artery or branches
visual field defect not scotomas or floaters |
|
dx of carotid disease
|
carotid duplex
CTA arteriography MRA |
|
carotid disease natural hx
|
depends on presentation
asymptomatic symptomatic - 2 year stroke risk of 15-30% |
|
carotid disease tx
|
secondary prevention/medical management
hypertension, smoking lipid, diabetes, antiplatelets |
|
surgical recommendations for carotid disease
|
based on severity of stenosis and symptoms
(a) optimal medical therapy without revascularization in symptomatic patients with <50% stenosis (b) medical when asymptomatic in patients <60% stenosis (c) carotid endarterectomy plus medical in symptomatic 50-99% stenosis (d) endarterectomy plus medical in asymptomatic 60-99% stenosis and low perioperative risk |
|
vertebrobasilar disease
|
embolization or low flow
symptoms - dizziness, vertigo, diplopia, blurred vision, ataxia, drop attacks epidemiology - much less common than carotid disease |
|
risk factors for vertebrobasillar disease
|
`age
smoking cardiovascular disease |
|
symptoms of vertebrobasilar disease
|
more common from flow related phenomena
systemic hypotension, brady/tachy. autonomic dysfunction/compression |
|
arteries potentially affected in vertebrobasillar disease
|
innominate
subclavian vertebral carotid |
|
presentation of vertebrobasillar
|
dizziness
vertigo diplopia blurred vision ataxia |
|
vertebrobasillar and precipitating factors
|
need to know
problems when head turning? problems when rising/standing? problems when using upper extremities? |
|
dx of vertebrobasilar
|
pulse examination of upper extremity blood pressures
duplex - transcranial doppler imaging |
|
tx of vertebrobasilar
|
hypertension management
smoking lipid, diabetes, antiplatelet agents increase pressure to basilar - subclavian or vertebral artery |
|
tx of extracranial occlusive disease with global hypoperfusion
|
treat anterior carotid disease first
|
|
Giant cell arteritis (temporal arteritis)
|
temporal headaches
jaw claudication polymyalgia rheumatic amaurosis constitutional symptoms dx temporary artery biopsy tx corticosteroids |
|
carotid artery dissections
|
spontaneous
traumatic can lead to pseudoaneurysms |
|
aneurysm
|
focal dilation of an artery involving an increase in diameter of at least 50% as compared to expected diameter
true - have the vessel layers false - have none of vessel wall layers |
|
aortic aneurysms
|
75% of all aneurysms
male> female atherosclerotic below renals |
|
pathogenesis of aortic aneurysms
|
(1)smooth muscle
(2)matrix proteins - elastin, collagen decreasing matrix concentrations from proximal to distal aorta (a) elastin - load bearing protein (b)collagen - safety net...resists AAA rupture (3) up regulation of matrix metalloproteinases (4) infection - chlamydia (5) autoimmune/inflammation (6) genetic |
|
Epidemiology of AAA
|
3-10% of people over 50yo
|
|
risk factors for AAA
|
elderly white males...peak at 80yo
M>F white>AA |
|
presentation of AAA
|
asymptomatic
occasionally feel pulsation |
|
rupture of AAA symptoms
|
most symptomatic
abdominal or back pain most palpable |
|
dx of AAA
|
imaging
ultrasound or CT angiography not good for screening...use CTA more often |
|
AAA screening
|
males >65
smokers family hx |
|
risk of AAA rupture
|
larger
>4 cm, screen every 6 months 5.5 cm surgery suggested |
|
when to do surgery for AAA
|
>5.5 cm diameter
life expectancy is greater than 2 years balance rupture risk, operative risk, life expectancy |
|
co-morbidities of AAA
|
coronary artery disease
pulmonary disease renal failure |
|
complications of AAA repair
|
early - MI
late - graft infection |
|
Aortic Dissection
|
non radiating chest pain
separation of aortic wall layers by extra luminal blood...usually through tear in intima blood may circulate between aortic lumen and abnormal channel uncommon clinical event survival low |
|
risk factors for Aortic dissection
|
male>female
location - ascending in 50-55yo descending aorta 65-70yo chronic systemic hypertension aortic diseases bicuspid aortic valve trauma cocaine pregnancy rebound from abrupt discontinuation of beta blocker therapy |
|
Marfan syndrome
|
hereditary connective tissue disorder
auto dominant defect in fibrillin 1 affects skeleton, heart, major vessels, lungs, eyes get dilation of aorta |
|
DeBakey classification of Aortic Dissection
|
type 1 - starts at valve goes all the way down
type 2 - just valve type 3 - descending aorta |
|
Tx of aorta dissection
|
ascending - surgery + medical control of bp (beta blockers)
descending - control with medical therapy for BP (beta blockers) |
|
clinical manifestations of aortic dissection
|
sharp pain
doesnt radiate hypertensive diastolic murmur |
|
dx of aortic dissection
|
imaging - CT, MRI
|
|
peripheral and visceral aneurysms
|
femoral - most common false aneurysms
popliteal - most common true aneurysm popliteal - tend to be limb threatening...more likely to thrombose of embolus then rupture more likely atherosclerotic male>female strongly associated with aneurysms elsewhere in body |
|
popliteal vs femoral aneurysm
|
popliteal - most common true anuerysm
usually atherosclerotic femoral - more common false aneurysm both more likely to embolus/thrombos then to rupture |
|
visceral aneurysms
|
splenic artery most common
biggest concern is rupture increased risk with pregnancy diameter 2-3cm |
|
BP =
|
(left ventricle end diastolic volume - left ventricle end systolic volume) x HR x SVR
depends on: how full at end of diastole how empty at systole - strength of contraction, difficulty in ejecting blood heart rate resistance in vasculature |
|
alpha 1 receptors
|
peripheral and splanchnic vasculature in smooth muscle
few in heart muscle stimulation: contraction of smooth muscle = vasoconstriction |
|
alpha 2 receptors
|
peripheral and splanchnic vasculature
fewer than alpha 1 in smooth muscle, cause contraction on presynaptic neurons, has negative feedback so less NE released with stimulation....net effect = less effect of future drugs also present in CNS causes sedation and pain relief |
|
beta 1 receptors
|
cardiac tissue
inotropic effect - increased contractility chronotropic effect - increased HR lusitropic effect - relaxes faster in systole peripheral - causes smooth muscle relaxation/vasodilation....minor role presynaptic receptors: causes positive feedback...increases enhanced release of future stimulus |
|
beta 2 receptors
|
cardiac tissue - much more beta 1 though
ratio of beta 1 to beta 2 increases in CHF (lose beta 1s) same effect as beta 1: inotropic chronotropic lusitropic peripheral - minor vasodilation bronchial smooth muscle - causes bronchodilation/relaxation |
|
dopamine receptors
|
cardiac tissue: 2 types
minimal effect but what it does is: iontropic CHRONOTROPIC splanchnic vasculature- causes vasodilation...major role of dopamine receptors CNS |
|
vasopressin receptors
|
peripheral vasculature - marked vasoconstriction
splanchnic vasculature - marked vasoconstriction |
|
beta receptor complex:
|
drug binds to receptor
receptor interacts with G protein G protein interacts with intracellular bound adenylcyclase adenylcyclase converts ATP to cAMP cAMP activates numerous cascades...one activates a phosphorylase that binds to calcium channels increaess amount of calcium that can come in, this increases amount of SR released calcium get strong contraction, also allows for calcium to get pumped out faster so relaxation faster phosphodiesterase degrades cAMP |
|
preload manipulation
|
can't measure directly
increase: give fluids alpha agonists in low doses |
|
afterload manipulation
|
left ventricle end systolic volume
not measured = amount coming out of ventricle and resistance to pumping out estimated with Hx and PE rx: vasodilators ACE inhibitors, nitroprusside PDE inhibitors |
|
contractility manipulation
|
also part of end systolic volume
not measured estimated by hx and PE = force generated by LV Rx. inotropes give beta PDE inhibitors |
|
HR manipulation
|
chronotropy
easily measured at high rates, cant fill fast enough rx. chronotropes beta, atropine, aminophyline, pacemaker |
|
SVR manipulation
|
vascular resistance
not measured, calculated rx. vasoconstrictors - alpha and vasopressin |
|
epinepherine
|
beta effects predominate (has some alpha at higher doses)
inotropic and chronotropic (Beta) use - sepsis, cardiogenic shock |
|
dobutamine
|
inotrope with vasodilator (reduces afterload)
beta mostly increases contractility and HR vasodilates and reduces afterload Use - MI |
|
norepinephrine
|
alpha effects - overwhelming vasoconstrictor
some beta high doses use - sepsis helps support heart in high doses |
|
phenylephrine
|
pure alpha, but weak
vasoconstriction and increased SVR mild sepsis, hypotension |
|
dopamine
|
use for renal support
beta and alpha at very high doses one drug, every receptor |
|
vasopressin
|
intense vasoconstriction, no alpha or beta
use - severe sepsis |
|
phosphodiesterase inhibitors
|
vasodilators and inotropes
augements beta stimulation smooth muscle relaxation keeps cAMP around longer |
|
MI pathology general
|
chronic - coronary atherosclerosis
acute - changes in plaque |
|
Dx of MI
|
coronary arteriogram
|
|
Acute symptoms of MI
|
unstable angina
Non ST- elevation myocardial infarction ST elevation myocardial infarction |
|
Acute Coronary syndromes
|
result from diminished coronary perfusion relative to demand
usually a hemorrhagic rupture of a fat laden, unstable atheroma with development of an occlusive platelet thrombus plaque rupture exposes interior to blood (1) platelet aggregation (2) coagulation thus get thrombus formation |
|
MI pathology specific
|
Initially, a sudden change occurs in the morphology of an atheromatous plaque - intraplaque hemmorrhage, ulceration, or fissuring
Platelets are exposed to subendothelial collagen and necrotic plaque contents, leading to adhesion, activation, and aggregation of platelets. This leads to buildup of platelet mass which gives rise to emboli or potentiates occlusive thrombosis. Simultaneously, tissue thromboplastin is released, activating the extrinsic pathway and fibrin deposition. Adherent activated platelets release thromboxane A2, serotonin, and platelet factors . These predispose to coagulation, favors vasospasm, and adds to the bulk of the thrombus. The thrombus evolves to become occlusive(often within minutes). |
|
uncommon MI pathology
|
erosion of endothelium exposing interior plaque
vasospasm from cocaine emboli from left atrium |
|
factors affecting MI plaque rupture
|
Sudden changes in intraluminal pressure or tone
Bending and twisting of an artery during each heart contraction Lipid content of plaque Thickness of fibrous cap Plaque shape Mechanical injury |
|
myocardial response to coronary occlusion
|
Get ischemia in region supplied
Starts at subendo and progresses to epicardium Get anaerobic glycolysis…leads to inadequate production of ATP and accumulation of noxious breakdown products Eventually get necrosis In absence of reperfusion – hypoxia and noxious metabolites leads to impaired ventricular function…predisposing to lethal arrhythmias Get transient diminished diastolic relaxation, abnormal systolic contraction, abnormal wall motion, diminished stroke volume |
|
dx of MI
|
With symptoms of ischemia
ECG Pathological Q waves |
|
presentation of MI
|
Acute onset of chest pain radiating to left arm and neck, shortness of breath
Atypical chest or epigastric discomfort |
|
risk factors for MI
|
Hypertension
Smoking High ldl, low hdl DM Family hx Sedentary lifestyle Obesity Age |
|
cardiac markers for MI
|
Detection in plasma released by injured myocardium
Troponin most specific Can use CK-MB AST, LDH Look at MB to CK, peaks early LDH peaks late Troponin peaks a few days after MI Troponin and CK don’t begin evaluating until at least 4 hrs Troponin correlated with outcome |
|
ECG findings in MI
|
ST elevation
T waves get very high..earliest sign of injury Ongoing injury will get ST elevation Thought to be persistent occlusive disorder…no flow restored Non ST Elevation MI More likely to have multivessel CAD Prior MIs Diabetes |
|
fields of coronary arteries
|
LAD – anterior, spetum/anteroseptum, anterolateral
L Circumflex – lateral or posterior RCA – inferior |
|
Prognosis of MI
|
Early – presence of arrhythmias
Late – determined by left ventricular function |
|
complications of MI
|
Arrhythmias
CHF Cardiogenic shock Pericarditis Scar or ventricular aneurysm |
|
CHD epidemiology in women
|
leading cause of mortality
major cause of disability - 55% over 75yo prevalence equal with men at 40-59yo |
|
Gender differences in MI
|
Men younger
Women less likely to undergo cardiac workup when presenting with chest pain Non-invasive studies have decreased sensitivity and specificity in women Higher in hospital stay Worse long term mortality Women have more risk factors Women have higher silent MI Women have atypical pattern for angina such as neck/jaw pain, dyspnea or fatigue |
|
coronary artery disease risk factors
|
Hypertension
Diabetes mellitus - relative risk increases with heart disease Dyslipidemia Smoking Age (men >45 women >55) Family hx |
|
obesity in women and MI
|
increasing problem in the US
women started fatter, getting fatter looking at wast circumference to hip higher ration, higher risk of CHD |
|
Smoking and women with MI
|
women smoke less than men
but still risk factor |
|
guidelines for LDL in MI
|
<160 with 0-1 risk factors
<100 with >2 risk factors <70 with CHD |
|
C reactive protein and CHD in women
|
CHD - sensitive marker for inflammation
associated with CHD statins will reduce |
|
Alcohol risk vs benefit in MI in women
|
drinking less than 2 a day is slightly beneficial in no risk factors
>1 risk factors, even better improvement >2 drinks, increases risk in women |
|
gender differences in risk factors
|
Diabetes much stronger predictor in women than men
High triglycerides worse for women Physical inactivity more prevalent in women Smoking may be stronger CRP levels higher in women |
|
Sex hormones in women with MI
|
estrogen - modifies lipid, arterial vasodilation, clot formation
progesterone unclear HERS study: HRT was associated with increase in invasive breast cancer without CAD benefit increased stroke and PE |
|
types of atherosclerosis lesions
|
fatty streak - innocuous, small, intracellular fat in intima
atheroma - raised, lipid center fibrous plaque - innocuous, intimal scar...problem when it ruptures |
|
Atheroma
|
sites: intimal, may involve media
arteries - aorta and its major branches elements: necrotic center of extracellular lipid fibrous cap - in contact with blood proliferation cells - myofibroblasts complications: within plaque - ulceration, fissuring thrombosis - often caused by ulceration medial damage - causing aneurysms hemorrhage into plaque calcification insidious: usually asymptomatic until 75% stenosis |
|
atheroma effects and clinical complications
|
Aortic branches: aneurysm, mural thrombus, rupture
Cardiac: infarct, ischemia, dysrhythmia, sudden death GI: ischemia, infarction Brain: infarction (Stroke), ischemia Peripheral: ischemic atrophy, claudication and gangrene Clinical complications of atherosclerosis: Carotids and vertebral: cerebrovascular disease Narrow, ulcerate, embolize, cause ischemia or infarct Coronary arteries: ischemic heart disease Narrow, ulcerate, or thrombose, causing ischemia, infarct, arrhythmia, heart failure Peripheral arteries: PVD Ischemia, gangrene, usually lower limbs or intestinal Aorta: aneurysm, rupture, atheroembolism, mural thrombus with thrombembolism |
|
properties of ion channels
|
selective but passive
unidirectional |
|
properties of exchanger channels
|
selective and passive
exchanged based on differences in concentration...not necessarily 1 to 1, can change direction depending on relative gradients |
|
properties of pump channels
|
selective and actively transport ions across membrane against concentrations or voltage gradients
ATP used in heart increase intracellular potassium and decrease intracellular sodium/calcium |
|
myocyte ion concentrations at steady state
|
K in
ca/Na out negatively charged inside (proteins inside are negative) -90mV |
|
cardiac myocyte channels at rest
|
Na closed
Ca closed some K closed some K open cell is actively pumping Na/Ca out K is leaking out passively |
|
Cardiac AP
Phase 4 |
resting state
Na closed Ca closed K closed, some leaking out -90mV |
|
Cardiac AP
Phase 0 |
rapid depolarization of Na into cell
|
|
Cardiac AP
Phase 1 |
very brief
some transient outward current corrects for over shoot of depolarizing |
|
Cardiac AP
Phase 2 |
plateau phase
calcium channels open - calcium into cell Na closed calcium takes long time to come in, the other receptors hold depolarized state Calcium binds to SR, letting out more calcium (Calcium activated calcium release) |
|
Cardiac AP
Phase 3 |
repolarization
calcium channels close Na closed K only ones open lose positive charge get to -90mV |
|
QRS and cardiac cycle
|
phase 0
|
|
ST and cardiac cycle
|
phase 2
|
|
T wave and cardiac cycle
|
phase 3
|
|
Refractory periods of cardiac cycle
|
(1)absolute refractory period
(2) effective refractory period (3)relative refractory period |
|
Absolute refractory period
|
all Na inactivated
Ca open cell is completely inexcitable Phase 2 cant make a new AP |
|
Effective Refractory Period
|
absolute + part of phase 3
Na channels still closed Some Ca channels closed - meaning they can reopen any inducible AP will be too weak to propagate Effectively cell is inexcitable |
|
Relative refractory period
|
cell is beginning to repolarize
not at rest yet (in phase 3) Na channels are still inactivated Ca channels are mostly closed but some can be reopened strong stimulus can induce an AP that will be lower in amplitude and slower in velocity...strong enough to propagate |
|
Automaticity
|
ability of cell to generate a tone rhythm
in cardiac cells - phase 4 resting takes external stimulus to get to threshold but some cells have inward leak of positive ions in phase 4 (pacemaker current - SA, AV, His/purkinje bundles mostly sodium, some calcium continueal leak of opsotive ions does bring cell to threshold, generating automatic rhythm SA/AV so leaky cant actually get to -90 or even threshold depolarization is driven by Ca channels because they do not have Na channels |
|
difference in nodal cell AP and cardiac AP
|
phase 0 - slower in nodal
phase 1 - does not occur in nodal (no Na to overshoot) phase 2 - Ca drive phase 0 instead phase 3 - occurs normally |
|
autonomic nervous system on cardiac AP
|
affect slope of phase 4 depolarization
sympathetic increase slope (epi) - mediated by calcium channels parasympathetics decrease slope and slightly hyperpolarize at end of phase 3...mediated through calcium channels |
|
Atrial myocytes and current flow
|
repolarize quickly
able to sustain rapid arrhythmias (refractory period) |
|
His, bundle, and purkinje and current flow
|
ERP longer than atrial
transmit signal through ventricles all basically same type of cells transmit individual heart beat quickly have more Na channels - each individual cell activates faster, plus more gap junctions, plus better gap junctions |
|
AV node and current flow
|
some automaticity, but real purpose is to conduct SA node
moves slowly - protects from atrial fibrillation becoming ventricular fibrillation |
|
dromotropic
|
alters current propagation
|
|
sympathetic stimulation of cardiac cycle
|
positive chronotropic, positive dromotropic
|
|
parasympathetic stimulation of cardiac cycle
|
negative chronotropic
negative dromotropic |
|
Bradyarrhythmias
|
(1) failure to generate
SA node automaticity failure - ischemia, fibrosis, metabolic disorders (2) failed impulse propagation SA block - current blocked AV block - physiologic or pathologic His bundle block - infranodal |
|
Escape rhythms
|
cells with normal automaticity - sinus node, AV node and his bundle, bundle branches, purkinje system
faster one wins |
|
normal sinus node beat
|
60-100 bpm
|
|
normal AV node/His bundle beat
|
40-60 bpm
|
|
normal bundle branches/purkinje system beat
|
30-40 bpm
|
|
ectopic atrial pacemakers
|
40-90s
blurs line between normal and abnormal usually not referred to as an escape rhythm reliable rhythm |
|
AV node/His bundle (AV junction)
|
junctional escape
good but less reliable, more easily suppressed |
|
Purkinje Network
|
includes bundle branches
ventricular escape not reliable, easily suppressed |
|
Tacharrhythmias
|
mechanism: abnormal automaticity
triggered activity reentry (1) abnormal automaticity - ischemia or metabolic derangement transforms phase 4 activity of atrial or ventricular myocyte (2) triggered activity after depolarizations had normal, then after you get something extra...if big enough get another depolarization early - phase 3 can be self perpetuating likely to get Torsades de Pointes - prolonged QT interval delayed - phase 4 intracellular calcium overload digoxin toxicity (3) reentry |
|
Typical AV node reentry tachy
|
normal: two pathways are present but during normal sinus rhythm wave fronts hit each other when cells are in refractory period so conduction is extinguished
slow pathway fast pathway abnormal: fast pathway is blocked slow pathway continues past where it would normally be extinguished, if it arrives at the right moment, cells can be reactivated and AP loops back onto the slow pathway unidirectional block premature beat beat comes in very soon after preceding beat |
|
atypical AV node reentry
|
get block in slow pathway
fast pathway circles around, and signal reenters through fast pathway |
|
Wolff-Parkinson White syndrome
|
accessory conduction pathway penetrates fibrous skeleton of heart
AV would be slow pathway accessory would be fast pathway |
|
Atrioventricular reentrant tachycardia
|
with a block in the accessory (fast pathway), signal goes down AV node and comes back up through accessory
|
|
VT after MI
|
primary mechanism of death from MI
scar becomes slow pathway normal becomes fast get reentry through infarct |
|
Class 2 antiarrhymthic drugs
|
beta blockers
Beta 1 in heart Beta 2 in vascular smooth muscle, bronchial smooth muscle MOA: block catecholamines of ANS (1)negative chronotropic effect - slow automaticity in sinus node and AV node by slowing phase 4 (2) negative dromotropic effect - slows velocity of conduction through AV node. slow ventricular response rate during atrial tachycardia (3) negative inotropic effect Types (a) cardioselective - beta 1 only (b) non-selective - 1, 2 and some alpha intrinsic sympathomimetic activity - block and stimulate beta receptors adverse: sinus bradycardia AV block can worsen patients who already have severe decompensated heart failure |
|
cardioselective beta blockers
|
atenolol
metoprolol esmolol |
|
atenolol
|
class 2 antarrhymthmic
beta blocker cardioselective adverse: sinus bradycardia AV block can worsen patients who already have severe decompensated heart failure |
|
metoprolol
|
class 2 antarrhymthmic
beta blocker cardioselective adverse: sinus bradycardia AV block can worsen patients who already have severe decompensated heart failure |
|
esmolol
|
class 2 antarrhymthmic
beta blocker cardioselective adverse: sinus bradycardia AV block can worsen patients who already have severe decompensated heart failure |
|
nonselective beta blockers
|
propranolol
lebetalol - also block some alpha carvedilol - also block some alpha adverse: sinus bradycardia AV block can worsen patients who already have severe decompensated heart failure |
|
propranolol
|
class 2 antiarrhymthmic
non selective beta blocker blocks 1 and 2 adverse: sinus bradycardia AV block can worsen patients who already have severe decompensated heart failure |
|
lebetalol
|
class 2 antiarrhymthmic
non selective beta blocker blocks beta 1 and 2 and alpha adverse: sinus bradycardia AV block can worsen patients who already have severe decompensated heart failure |
|
carvedilol
|
class 2 antiarrhymthmic
non selective beta blocker blocks beta 1 and 2 and alpha adverse: sinus bradycardia AV block can worsen patients who already have severe decompensated heart failure |
|
Class 4 antiarrhymthmic
|
calcium channel blockers
Types - dihydropyridine (DHP) non dihydropyridine (non-DHP) diltiazem verapamil block Ca channels in heart (DHP) only affect sinus and AV nodal cells (mostly AV) effects: negative chronotropy - sinus node slowed down AV - junctional escape shutdown Negative dromotropy effect on AV node: terminate reentry circuit negative inotropy contraindicated for patients with systolic heart failure adverse: too much negative chronotropy, dromotropy, inotropy hypotension peripheral edema drug interactions |
|
diltiazem
|
block Ca channels in heart (DHP)
only affect sinus and AV nodal cells (mostly AV) effects: negative chronotropy - sinus node slowed down AV - junctional escape shutdown Negative dromotropy effect on AV node: terminate reentry circuit negative inotropy contraindicated for patients with systolic heart failure adverse: too much negative chronotropy, dromotropy, inotropy hypotension peripheral edema drug interactions |
|
verapamil
|
Class 4
block Ca channels in heart (DHP) only affect sinus and AV nodal cells (mostly AV) effects: negative chronotropy - sinus node slowed down AV - junctional escape shutdown Negative dromotropy effect on AV node: terminate reentry circuit negative inotropy contraindicated for patients with systolic heart failure adverse: too much negative chronotropy, dromotropy, inotropy hypotension peripheral edema drug interactions |
|
digoxin
|
form of digitalis, cardiac glycoside
positive inotrope: poisons Na/K pump increases Na concentration inside cell Na/Ca exchanger keeps more Ca in cell to balance net: more calcium enter SR so more Ca released Use: increases vagal tone AV node primary target - no hypotension, mild positive inotrope less effective than older drugs at slowing AV nodal conduction narrow therapeutic index adverse:nausea vomiting, visual disturbances (yellow, green halos) high grade AV block along atrial tachycardias ventricular tachy due to delayed afterdepolarizations renal toxicity |
|
adenosine
|
natural occurring substance
Give as rapid IV, very short half life Bronchospasm in an asthmatic does not go away Large doses can cause atrial fibrillation Primary use: To block AV node Slight affect on sinus node Terminate reentry rhythms that include AV node |
|
Class 1 antiarrhythmias
|
Na channel blockers
Drug slows upstroke of phase 0 Prolongs QRS duration Blockade of sodium channels: less available for conduction Raise the threshold for initiation of action potential Decrease slope of phase 4 Takes larger stimulus to excite each cell (larger threshold) Slows or terminates automaticity Effect on conduction: Na channel blockade causes each cell to activate a bit more slowly Cumulative effect is to slow conduction through the affected tissue Use: convert unidirectional block to bidirectional block Slow the slow pathway so much that it no longer conducts Bad effect on reentry: Slow either pathway just enough to make the reentry circuit virtually incessant Don’t give to prior MI unless they have defibrillator |
|
Class 1 A:
|
prolong QRS and QT
quinidine procainamide disopryamide advese: Torsades de pointes |
|
quinidine
|
class 1A antiarrhythmic
blocks Na channels Major side effects: GI nausea vomiting Diarrhea CNS: cinchonism – confusion, visual, tinnitus Autoimmune thrombocytopenia Major interaction with digoxin |
|
procinamide
|
Type 1A antiarrhythmic
Na channel blocker IV only Breakdown product = NAPA Active metabolite Metabolism depends on rate of acetylation Blood level = check both procainamide + NAPA Lupus-like syndrome |
|
disopyramide
|
Type 1A antiarrhythmic
Na channel blocker Strong anticholinergic effect – dry mouth, urinary retention, constipation, dry eyes Negative inotrope – can use with hypertrophic cardiomyopathy |
|
Class 1B antiarrhytmic
|
Na channel blocker
lidocaine mexiletine |
|
Lidocaine
|
Class 1B antiarrhythmic
block Na channels Shorten QT interval Target ventricular cells, ischemic tissue Lidocaine: IV only Cleared by liver…careful with liver disease With heart failure, liver doesn’t have good perfusion CNS side effects: can be serious if levels get too high…confusion, seizures |
|
mexiletine
|
Class 1B antiarrhytmic
Na channel blocker Oral Mixes well with other antiarrhythmics Basically oral lidocaine…liver toxicity, cns |
|
Class 1C antiarrhythmic
|
Na channel blockers
Flecainide Propafenone prolong QRS no difference in QT negative inotropes |
|
flecainaide
|
Class 1c
Na channel blockers Most potent Na channel blockers Markedly decerase upstroke of phase 0 Clean durgs – no effect on K channels No direct effect on QT interval Can cause bad arrhythmias, but not Torsades Negative inotropes – contraindicated in systolic heart failure Primarily used for atrial arrhythmias (AFib) accessory pathways Side effects are common but not severe Fatigue Visual disturbances |
|
propafenone
|
Class 1c
Na channel blockers Most potent Na channel blockers Markedly decerase upstroke of phase 0 Clean durgs – no effect on K channels No direct effect on QT interval Can cause bad arrhythmias, but not Torsades Negative inotropes – contraindicated in systolic heart failure Primarily used for atrial arrhythmias (AFib) accessory pathways Has beta blocking properties Mild CNS symptoms – dizziness Use dependence: Na channel blocking drugs bind preferentially to open channels More open, more being blocked Means they are more effective at faster HR |
|
Class 3 antiarrhythmics
|
K channel blockers
sotalol dofetilide and ibutilide amiodarone dronedarone Reverse use dependence: Greater affect the slower HR Less useful for Afib (good for prevention, not stopping) Also means that bad arrhythmias usch as Torsades are more likely during slower HR if QT is prolonged Prolong phase 3…lengthening refractory period Torsades: more likely when Too much drug Hypokalemia Bradycardia |
|
Sotalol
|
class 3 antiarrhythmic
K channel blocker Also has beta blocker activity Cleared by kidney – renal toxicity QT must monitored periodically Reverse use dependence: Greater affect the slower HR Less useful for Afib (good for prevention, not stopping) Also means that bad arrhythmias usch as Torsades are more likely during slower HR if QT is prolonged Prolong phase 3…lengthening refractory period Torsades: more likely when Too much drug Hypokalemia Bradycardia Use with patients with MI scar |
|
dofetilide and ibutilide
|
Class 3
ibutilide = IV convert Afib torsades in 10% dofetilide = oral cleared by liver and KIDNEY relatively safe for heart failure Reverse use dependence: Greater affect the slower HR Less useful for Afib (good for prevention, not stopping) Also means that bad arrhythmias usch as Torsades are more likely during slower HR if QT is prolonged Prolong phase 3…lengthening refractory period Torsades: more likely when Too much drug Hypokalemia Bradycardia Use with patients with MI scar |
|
Amiodarone
|
Class 3
Safest antiarrhythmic drug for your heart, most dangerous for rest of body Prolongs QT but rarely causes Torsades Don’t need to monitor QT Rarely causes Torsades Almost never causes ventricular arrhythmias Adverse: Multiple toxicities require routine monitoring Eyes – corneal deposits, optic neuropathy Hypothyroidism – common easily remedied Hyperthyroidism rare Hepatic injury Pulmonary toxicity –irreverisble but usually after several years (look at age of pt) Skin photosensitivity – bluish Interacts with warfarin Has some properties of all antiarrhythmics K, Na, Ca channel blockers |
|
dronedarone
|
class 3 antiarrhythmic
Supposedly like amiodarone without toxicities But need to monitor QT, torsades probably low Interferes with creatinine secretion – raises serum creatinine level but renal function fine |
|
idiopathic necrotizing arteritis
|
(1)Kawasaki's disease
(2) takayasu arteritis (3) Thromboangiitis obliterans (Buerger's Disease) |
|
kawasaki's disease
|
idiopathic necrotizing arteritis
young children under 5yo high fever enlarged lymph nodes rash 10% get coronary artery autoimmune attack weakens wall, get aneurysm or dilation |
|
Takayasu arteritis
|
Thickening of aortic arch
Blindness, cns deficits, decreased pulses in upper extremities Microscopic = giant cell artitis Women most commonly affected |
|
Thromboangiitis obliterans (Buerger's Disease)
|
Pain and ischemia in legs/arms
Relatively young men Leads to gangrene Genetic predisposition Almost exclusively smokers Inflammatory with thrombosis Lesion – cellular thrombosis with inflammation |
|
Phlebitis: inflammation of veins
|
Usually with thrombosis
Caused by injury Pylephlebitis – portal vein…associated with appendicitis Dural sinuses Pulmonary veins in pneumonia Examples: iliofemoral veins in puerperal sepsis Hepato-veno-occlusive disease from chemo Migratory thrombophlebitis – Trousseau Syndrome Idiopathic trhombophlebitis |
|
Phlebothrombosis
|
venous thrombosis without inflammation
Usually in deep veins or pelvic veins Exact incidence uncertain Pain, tenderness, swelling or may be symptomatic Complications: pulmonary embolus – 50% Clots usually form in relation to valve cusps, propagate upwards |
|
vericose veins
|
Abnormal dilated, tortuous veins
Produced by prolonged increase in intraluminal pressure Often in relation to injury or defect of the vein proximally Sites: legs in estimated 20% of population Clusters in families Complications- inflammation, thrombosis, stasis dermatitis, ulceration of skin No pulmonary embolism Sites: perianal – hemorrhoids Testis – varicocele Esophageal varices hepatic cirrhosis, portal hypertension…can hemorrhage |
|
Atherosclerotic aneurysm
|
Age: >50, males 5:1, relatively common
Location : abdominal aorta (97%) Usually below renals, may involve iliacs, but may occur in thoracic aorta Mechanism: atheromasmedial destruction, ulcerated plaques Presentation: pulsatile abdominal mass or pain Rupture causes pain, swelling and shock Incidentally on x ray (calcified) Complications: rupture (retroperitoneal hemorrhage) Stenosis of ureter by pressure or fibrosis Occlusion of aortic branch (renal, mesenteric) Embolism Rupture: related to size Greater than 7cm 80% rupture Use ultrasound for cut-off Therapy: surgery |
|
syphilitic dissection
|
Location: ascending thoracic aorta and arch
Mechanism: tertiary syphilis involves vasa vasorum causes vasculitis and medial damage of aorta Presentation: dyspnea, stridor, dysphagia, cough, pain Congestive heart failure due to aortic insufficiency Aneurysm can compress esophagus Causes: heart failure or hemorrhage Therapy: surgery |
|
mycotic aneurysm
|
Mycotic refers to any infection, not necessarily fungal
Mechanism: infection causes destruction of media Complication: infarcts distally, septic or bland Cause: sequel of infective endocarditis or endarteritis…can embolism to brain carrying infection |
|
dissecting hematoma of aorta
|
Age: 40-60 males
Location: intimal tear in ascending aorta Types: A: most common involves ascending aorta and may extend distally B: begins distal to subclavian artery, extends distally – better prognosis than A Mechanism: hypertension Trauma Creates false lumen Presentation: 85% pain in chest or radiating to back Usually normal or elevated blood pressure May have MI Therapy: anti hypertensives, surgery |
|
Stenotic lesions cause what kind of hypertrophy
|
cause pressure overload, and myocardial hypertrophy = concentric hypertrophy
|
|
regurgitant lesions cause what kind of hypertrophy
|
volume overload, eccentric hypertrophy
|
|
Rheumatic heart disease
|
uncommon in Us
|
|
most common valvular lesion in US
|
aortic stenosis
|
|
Aortic stenosis and bicuspid valve
|
Bicuspid Aortic valves 1-2% population
Frequent cause of symptomatic aortic stenosis in young patients Associated with other congenital abnormalities in 20% of cases 80% of coarctation patients have Bicuspid |
|
aortic stenosis etiology
|
Young patient: think bicuspid
Male more than female Old patient – think degenerative: MOST COMMON in older patients |
|
aortic stenosis symptoms
|
Cardinal symptoms
Chest pain (angina) Reduced coronary flow reserve Increased demand – high afterload Syncope Dyspnea on exertion Impaired exercise tolerance Heart failure GI bleeding possible |
|
classification of aortic stenosis symptoms
|
Classification of AS severity
Normal aortic valve area 2-3cm Mild AS >1.5cm Moderate As 1.0-1.5 cm Severe AS <1.0 cm |
|
when to treat aortic stenosis
|
Asymptomatic patients – follow expectantly
Endocarditis prophalaxis Survey with echo annually when severe AS or symptoms change Surgery – severe and symptomatic AS If need heart surgery (bypass, etc.) for another reason, replace even if asymptomatic |
|
aortic regurgitation causes
|
Causes:
Bicuspid – coarctations and aortic root dilation Infective endocarditis Rheumatic heart disease Radiation Subvalvular causes (septal defects) Etiologies: Chronic: rheumatic disease Congenital bicuspid Myoxamtous disease Marfan’s Syphilis Acute: dissection Infective endocarditis Traumatic |
|
symptoms of aortic regurgitation
|
Chronic AR – asymptomatic for a long time
Symptoms – exertional dyspnea, orthopnea, PND Syncope and angina are less common Uncomfortable awareness of heart beat especially lying down |
|
aortic regurgitation PE
|
PE – apical impulse diffuse
Tachycardia Diastolic descrendo murmur, begins just after second heart sound at apex S3 and S4 Severity of AR correlates with duration of murmur Murmur best heard along RIGHT sterna border Austin Flint murmur – apical rumble due to regurgitation trying to close mitral valve (valve normally trying to open)…blowing diastolic murmur Bobbing of head Capillary pulsations Clubbing of fingers |
|
treatment for aortic regurgitation
|
Dilated aortic root or mild LV dysfunction – class I indication for surgery
Don’t do surgery if: normal systolic and asymptomatic with Chamber size normal |
|
mitral valve stenosis etiology and prevalence
|
Primarily result of rheumatic fever
Rarely congenital Slightly female to male Don’t see in the US much unless poor access to care |
|
mitral valve stenosis downstream affects
|
IN crease in left atrial pressure, can cause increase in pulmonary congestion and edema
Dypsnea common Mitral valve stenosis associated with diastolic murmur because of turbulence Diastolic murmur always pathologic |
|
secondary concerns with mitral valve stenosis
|
Increase in mitral valve gradient – causes shortened diastolic phase
As atria expand, can get loss in atrial ventricular synchrony….get atrial fibrillation Likely to get strokes Valvular atrial fibrillation high risk of strokes Fusion causes valve to become more spherical – less efficient Tightening of valve – get turbulent flow in atrium Tend to clot Clots found in atrial appendage likely to embolize to brain |
|
primary affects of mitral stenosis
|
Consequences:
Reduced ventricular filling Reduced stroke volume Decreased cardiac out put Stroke volume low enough may result in a reduction in aortic pressure |
|
mitral valve regurgitation
acute |
Acute – infective endocarditis
Myxomatous disease Ischemic heart disease PE: loud S4, heard best at apex, radiates to axilla |
|
mitral valve regurgitation
chronic |
Chronic – myxomatous disease (prolapsed)
Rheumatic heart disease Annulo-aortic ectasia – dilated aortic root Ischemia – kill papillary muscle Chronic: Leak into left atrium Left ventricle volume load Compensation – left ventricle dilates and hypertrophies Increase in stroke volume Left atrium dilates |
|
mitral valve stenosis PE findings
|
PE:
Jugular venous distension – normal until late Carotids – normal until late Apex impulse – laterally displaced and hyperdynamic Pan systolic murmur in apex, axilla right precordium or back |
|
mitral valve stenosis dx
|
Dx: systolic displace of mitral leaflet into atrium of at least 3mm, mitral regurgitation
Can have prolapsed but no leak can be of little concern |
|
mitral valve stenosis tx
|
Tx. Surgery if see signs of atrium/ventricle dilation
|
|
normal changes in cardiovascular system with aging
|
increased stiffness of the left ventricle and arteries, and decreased maximal heart rate and cardiac output during exercise
3. These normal age related changes reduce cardiovascular reserve capacity, and thereby lower the threshold for development of common cardiovascular diseases, and reduce the ability to adapt to them |
|
when does cardiovascular risk for women rise?
|
5. Cardiovascular risk for women rises after menopause and becomes similar to men by age by 70
|
|
cardiovascular disorders unique to elderly?
|
diastolic heart failure
calcific aortic stenosis |
|
presentation of elderly with MI
|
Atypical presentations: 1/3 of elderly
Confusion Dyspnea Lassitude New onset of CHF Syncope Stroke Increases with age and women |
|
gender differences in CHF
|
women more likely to have normal ejection fraction heart failure
Differences in preserved vs reduced PEF – old, women, coronary artery disease reduced, morbidity Reduced – middle aged, men, CAD common, morbidity, |
|
venous insufficiency ulcer characteristics
|
gaiter distribution
larger with irregular border shallow with moist, granulating base surrounding pigmentation and inflammation tx. compression and elevation |
|
arterial insufficiency ulcer characteristics
|
painful with punched out appearance
dorsum of foot or toes surrounding skin pale or molted poorly developed granulation tissue at wound base little bleeding seen with probing or debridment tx. revascularization |
|
neurotropic ulcer characteristics
|
completely painless
bleed with manipulation appear over pressure points of toe or foot surrounded by acut and chronic inflammatory reaction associated with longstanding diabetes with neuropathy tx. meticulous wound and foot care, well fitting shoes |
|
arterial baroreflex vasconstriction
|
Receptors are sensitive to stretch…aortic arch and carotid sinus
Graded response firing increases with increased stretch sensitive to stretch, pulse stretch, rate of change small deviations result in large change in firing because it responds to slope of curve (slope of change, not absolute amount of change) drop in pressure = less firing How it works: From baroreceptor to nucleus tract soliatirus to either(1) CVLM – depressor or (2) RVLM – pressor centers in medulla Barorecptor input into NTS…NTS sends excitatory to CVLM..CVLM projects inhibitory signal to RVLM…get less output from pressor centers….low BP Baroreceptor input into NTS…NTS decreases signal to CVLM, CVLM has decreased firing on RVLM..RVLM increases vasoconstriction and BP |
|
parasympathetic baroreflex of heart
|
Cell bodies originate in dorsal vagal/nucleus ambiguous of medulla
Excitatory connection to dorsal motor nucules and nucleus ambiguous with secondary projections to sympathetic Get increased parasympathetic firing and thus decreased on heart |
|
chemoreceptor control
|
Regulate respiratory activity
(a) Peripheral receptors Carotid and aortic bodies Increased CO2, acid, decreased O2, and hypoperfusion Sends info via NTS to medulla Humoral Control: Catecholamines: Released by adrenal medulla 80% Epi, 20% NE NE also from end of sympathetic NE stimulates release of Renin |
|
receptor dependent vasodilators
local vascular control |
histamine
sub P SE ACh |
|
receptor independent vasodilators
local vascular control |
sodium
nitroprusside NO donor |
|
vasocontrictors
|
PE
NE NPY coreleased with NE augments actions of NE Angiotensin II arginine vasopressin NE, Epi Endothelin Increased PO2 |
|
Special circulaitons
coronary |
compensate increased demand with increased flow
local factors predominate over neural use adenosine (vasodilator) |
|
special circulation
cerebral |
local factors predominate over neural
|
|
special circulation
skeletal muscle circulation |
local factors and hypoxia regulate flow
metabolites out compete sympathetic vasoconstriction |
|
special circulation
skin |
control by neural and physical factors most important
tonic sympathetic tonic hot vs cold temps |
|
special circulation
splanchnic circulation |
reservoir of blood
use to redistribute blood as needed neural control predominates |
|
special circulation
renal |
two capillary segments in series
strong autoregulation - depends on sympathetic tone |
|
special circulation
pulmonary |
two criculations
(1) pulmonary - hypoxia causes vasoconstriction to maintain proper perfusion ratios (2) bronchial - maintain flow to trachea and bronchial structures |
|
MI of LAD
|
anteroseptal LV
|
|
MI of LCX
|
lateral LV
|
|
MI of RCA
|
posteroseptal LV
|
|
stages of MI
|
early acute: 6-24 hrs
acute 1-6 days organizing 1-3wks Remote 3mos or more |
|
Early Acute MI
|
6-24 hrs
thin wavy fibers, eosinophilia pallor, patchy, hyperemia |
|
Acute MI
|
1-6 days
obvious pale, yellow necrotic myocytes |
|
organizing MI
|
1-3wks
red-brown edge around pale center granulation tissue, acute and or chronic inflammation |
|
remote MI
|
3 mos or longer
firm, white, scar collagen |
|
Transmural infarcts
|
infarction of full thickness of ventricular wall
caused by severe CAD with acute plaque disruption and occlusive thrombosis |
|
subendocardial infarct
|
limited to inner 1/3 to 1/2 of ventricular wall
diminished perfusion |
|
transmural infarct pathogenesis
|
90% due to CA stenosis and disrupted plaques
significant plaques mainly in proximal CA less common: vasospasm, PLT aggregation, emboli complete vessel occlusion may not cause MI if sufficient collateral flow Almost all IN LV initial event - plaque disruption with thrombosis following |
|
subendocardial infarct pathogenesis
|
diffuse CAD and global perfusion made transiently critical by increased demand, vasospasm, hypotension
disrupted plaque with overlying thrombus that lyses , thus limiting extent of MI |
|
Rupture of MI which stage?
|
Acute more likely
|
|
LV aneurysm of MI in which stage?
|
organizing
|
|
CHF of MI in which phase?
|
early acute
|
|
dysrhythmia of MI in which stage?
|
early acute
|
|
pericarditis of MI in which stage?
|
organizing fibrous in remote
|
|
chronic ischemic heart disease
|
due to left heart failure
Pure RV failure tdue to intrinsic lung disease major manifestations - portal, systemic and dependent peripheral congestion and edema and effusions |
|
Idiopathic dilated cardiomyopathy
|
results from viral myocarditis or toxic myocarditis
male>female african americans>caucasains genetic predisposition heart biopsy is not diagnostic treat like CHF - beta blocker, angiotensin, aldosterone antagonist |
|
Viral myocarditis
|
probably cause of idiopathic cardiomyopathy
coxsackie B most common agent immunologic mechanism - develops weeks after original infection enhanced susceptibility - animal studies...radiation, malnutrition, steriods, exercise, previous MI tends to be more aggressive in infants and pregnant women myocytes infiltrate heart other: HIV, CMV, hepatitis ricketsia bacterial spirochetal protozal |
|
peripartum cardiomyopathy
|
distinct type of cardiomyopathy related to pregnancy
clear relationship to recent pregnancy with high risk of relapse on subsequent pregnancies embolic phenomena common better prognosis evidance of inflammation good prognosticator |
|
hypertrophic cardiomyopathy
|
cardiac muscle disease characterized by abnormal hypertrophy, mainly involving ventricular septum
histology: myofibrillar disarray functional abnormalities outflow tract obstruction diastolic dysfunction atrial and ventricular arrhythmias 50% autodominant thickening of septum impingnes on outflow tract. plus systolic anterior movement of mitral valve causing mitral regurgitation. have decreased pressure in outflow tract and aorta |
|
Infectious pericarditis causative agents
|
coxsackie, echo virus, and HIV
TB outside US |
|
non-infectious pericarditis causative agents
|
idiopathic
neoplasm - metastatic lung, breast or primary mesothelioma renal failure |
|
hypersensitive pericarditis causes
|
collagen vascular disease - LUPUS, rheumatoid arthitis
drug induced post MI |
|
Dx of pericarditis
|
diffuse ST segment elevation in early stage
depresison of PR segment and T wave inversion in late stages or eletrical alternans |
|
Dx of pericardial effusions
|
CXR
ECG - low voltage echo |
|
cardiac tamponade
|
accumulation of fluid in the pericardial space leads to an increased pericardial pressure
increased pressure = cardiac compression and impaired diastolic ventricular filling....means decreased cardiac output |
|
clinical presentation of cardiac tamponade
|
mimics heart failure
dyspnea on exertion and orthopnea trachycardia, tachypnea jugular venous distention pulsus paradoxus - typically 10mm variation in systole exhale/inhale...greater than 10 then cardiac tamponade |
|
constrictive paricarditis
|
results from dense fibrosis and adhesion of the parietal and visceral layers
creates rigid cause around heart early ventricular filling is unimpeded but diastolic filling is subsequently abruptly reduced as a result of the ventricles fo fill secondary to the restraints imposed by a rigid, thickened, and calcified pericardium |
|
presentation of constrictive pericarditis
|
right heart failure
weakness, dyspnea, orthopnea, anorexia peripheral edema, hepatomegaly, splenomegaloy, ascites prominent Y decent with jugular venous pressures exaggerated filling of jugular with inspiration effects end diastole when ventricle volume is higher |
|
non penetrating trauma and heart
|
most commonly causes cardiac contusion - new arrhythmias and ECG changes
can have transaction of descending thoracic aorta |